Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

PEComas: the past, the present and the future.

Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F.

Virchows Arch. 2008 Feb;452(2):119-32. Epub 2007 Dec 14. Review.

2.

Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms.

Kenerson H, Folpe AL, Takayama TK, Yeung RS.

Hum Pathol. 2007 Sep;38(9):1361-71. Epub 2007 May 22.

3.
4.

Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney.

Martignoni G, Bonetti F, Chilosi M, Brunelli M, Segala D, Amin MB, Argani P, Eble JN, Gobbo S, Pea M.

Mod Pathol. 2012 Jan;25(1):100-11. doi: 10.1038/modpathol.2011.136. Epub 2011 Aug 26.

5.

Perivascular epithelioid cell tumor (PEComa) in the genitourinary tract.

Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F.

Adv Anat Pathol. 2007 Jan;14(1):36-41. Review.

PMID:
17198309
6.

Renal disease in adults with TSC2/PKD1 contiguous gene syndrome.

Martignoni G, Bonetti F, Pea M, Tardanico R, Brunelli M, Eble JN.

Am J Surg Pathol. 2002 Feb;26(2):198-205.

PMID:
11812941
8.

Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.

Stepanova V, Dergilev KV, Holman KR, Parfyonova YV, Tsokolaeva ZI, Teter M, Atochina-Vasserman EN, Volgina A, Zaitsev SV, Lewis SP, Zabozlaev FG, Obraztsova K, Krymskaya VP, Cines DB.

J Biol Chem. 2017 Dec 15;292(50):20528-20543. doi: 10.1074/jbc.M117.799593. Epub 2017 Sep 27.

PMID:
28972182
10.

Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex.

Liang N, Zhang C, Dill P, Panasyuk G, Pion D, Koka V, Gallazzini M, Olson EN, Lam H, Henske EP, Dong Z, Apte U, Pallet N, Johnson RL, Terzi F, Kwiatkowski DJ, Scoazec JY, Martignoni G, Pende M.

J Exp Med. 2014 Oct 20;211(11):2249-63. doi: 10.1084/jem.20140341. Epub 2014 Oct 6.

11.

PEComas: a review with emphasis on cutaneous lesions.

Walsh SN, Sang├╝eza OP.

Semin Diagn Pathol. 2009 Aug;26(3):123-30. Review.

PMID:
20043511
12.

Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.

Li C, Zhang E, Sun Y, Lee PS, Zhan Y, Guo Y, Osorio JC, Rosas IO, Xu KF, Kwiatkowski DJ, Yu JJ.

PLoS One. 2014 Oct 27;9(10):e104809. doi: 10.1371/journal.pone.0104809. eCollection 2014.

13.

Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study.

Martignoni G, Pea M, Bonetti F, Zamboni G, Carbonara C, Longa L, Zancanaro C, Maran M, Brisigotti M, Mariuzzi GM.

Am J Surg Pathol. 1998 Jun;22(6):663-72.

PMID:
9630173
14.

PEComa: what do we know so far?

Hornick JL, Fletcher CD.

Histopathology. 2006 Jan;48(1):75-82. Review.

PMID:
16359539
15.

Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors.

Martignoni G, Pea M, Reghellin D, Gobbo S, Zamboni G, Chilosi M, Bonetti F.

Arch Pathol Lab Med. 2010 Jan;134(1):33-40. doi: 10.1043/2008-0542-RAR1.1.

PMID:
20073603
16.

Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex.

Guo Y, Dreier JR, Cao J, Du H, Granter SR, Kwiatkowski DJ.

PLoS One. 2016 Dec 1;11(12):e0167384. doi: 10.1371/journal.pone.0167384. eCollection 2016.

18.

Alterations of the mTOR pathway in hepatic angiomyolipoma with emphasis on the epithelioid variant and loss of heterogeneity of TSC1/TSC2.

Huang SC, Chuang HC, Chen TD, Chi CL, Ng KF, Yeh TS, Chen TC.

Histopathology. 2015 Apr;66(5):695-705. doi: 10.1111/his.12551. Epub 2015 Jan 20.

PMID:
25234729
19.

Malignant epithelioid angiomyolipoma of the kidney in a patient with tuberous sclerosis: an autopsy case report with p53 gene mutation analysis.

Sato K, Ueda Y, Tachibana H, Miyazawa K, Chikazawa I, Kaji S, Nojima T, Katsuda S.

Pathol Res Pract. 2008;204(10):771-7. doi: 10.1016/j.prp.2008.04.008. Epub 2008 Jun 10.

PMID:
18547741
20.

Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor.

Lesma E, Grande V, Carelli S, Brancaccio D, Canevini MP, Alfano RM, Coggi G, Di Giulio AM, Gorio A.

Am J Pathol. 2005 Oct;167(4):1093-103.

Supplemental Content

Support Center